Apr 27, 2026 04:15PM BofA Securities stays Buy on Catalyst Pharma (CPRX) amid Angelini acquisition interest reports

Apr 27, 2026 03:36PM Catalyst Pharmaceuticals (CPRX) 3600 contracts of May 30 calls trade, share price up 7.9%

Apr 27, 2026 12:06PM Italy's Angelini Said To Explore Acquisition Of Catalyst Pharma - Bloomberg

Apr 14, 2026 02:12PM Catalyst Pharmaceuticals (CPRX) 1500 contracts of September 30 calls trade

Mar 6, 2026 08:04AM Catalyst Pharmaceuticals presents DMD research at MDA conference

Feb 27, 2026 06:00AM Oppenheimer Reiterates Outperform Rating on Catalyst Pharmaceutical Partners (CPRX)

Feb 25, 2026 04:35PM Catalyst Pharmaceuticals (CPRX) Tops Q4 EPS by 37c, Offers Guidance

Nov 5, 2025 04:47PM Catalyst Pharmaceuticals (CPRX) Tops Q3 EPS by 35c; offers guidance

Aug 25, 2025 08:03AM Catalyst Pharmaceuticals settles FIRDAPSE patent dispute with Lupin

Aug 6, 2025 04:54PM Catalyst Pharmaceuticals (CPRX) Tops Q2 EPS by 29c ; Offers Guidance

Jun 2, 2025 08:08AM Catalyst Pharmaceuticals (CPRX) Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer

May 7, 2025 04:26PM Catalyst Pharmaceuticals (CPRX) Tops Q1 EPS by 34c, Beats on Revenue; Offers FY25 Revenue Guidance

Apr 8, 2025 08:07AM Catalyst Pharmaceuticals (CPRX) Announces Health Canada’s Acceptance of AGAMREE New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals

Apr 8, 2025 08:06AM Catalyst Pharmaceuticals (CPRX) New Drug Submission for AGAMREE Accepted for Priority Review by Health Canada for the Treatment of Duchenne Muscular Dystrophy

Mar 13, 2025 06:58AM Cantor Biotech industry report, buying value in RevGens

Feb 28, 2025 07:08AM Catalyst Pharmaceutical Partners (CPRX) PT Raised to $40 at Stephens

Feb 26, 2025 04:24PM Catalyst Pharmaceuticals (CPRX) Tops Q4 EPS by 38c, Beats on Revenue; Offers FY25 Revenue Guidance

Feb 4, 2025 05:07AM Baird Starts Catalyst Pharmaceutical Partners (CPRX) at Outperform

Jan 21, 2025 02:21PM Oppenheimer Reiterates Outperform Rating on Catalyst Pharmaceutical Partners (CPRX)

Jan 21, 2025 08:20AM Catalyst Pharmaceuticals (CPRX) Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE in Japan

Jan 8, 2025 03:06PM Oppenheimer on Catalyst Pharmaceutical (CPRX): 'We believe that uncertainty around this topic had kept many on the sidelines and that today's update will facilitate investor interest'

Jan 8, 2025 03:05PM BofA on Catalyst Pharmaceutical (CPRX): 'Firdapse IP settlement sets favorable LOE, assuming other 2 generic filers follow suit'

Jan 8, 2025 03:04PM Citi Catalyst Pharmaceutical (CPRX): 'Firdapse Patent Litigation Settlement with Teva Meaningfully Derisks LOE Overhang on Shares'

Jan 8, 2025 12:31PM Catalyst Pharmaceuticals (CPRX) Announces Settlement of FIRDAPSE Patent Litigation with Teva Pharmaceuticals

Jan 8, 2025 12:25PM Catalyst Pharmaceuticals (CPRX) Halted, News Pending

Dec 17, 2024 06:17AM BofA Updates Endeavor List

Nov 6, 2024 04:23PM Catalyst Pharmaceuticals (CPRX) Tops Q3 EPS by 27c, provides guidance

Sep 24, 2024 06:20AM Catalyst Pharmaceuticals (CPRX) Announces Sub-Licensee DyDo Pharma Received Approval to Commercialize FIRDAPSE in Japan

Aug 12, 2024 06:28AM Catalyst Pharmaceutical Partners (CPRX) PT Raised to $30 at H.C. Wainwright

Aug 9, 2024 04:56AM Catalyst Pharmaceutical Partners (CPRX) PT Raised to $31 at Citi

Aug 7, 2024 04:24PM Catalyst Pharmaceuticals (CPRX) Tops Q2 EPS by 33c, Beats on Revenue; Offers FY24 Revenue Guidance

Aug 7, 2024 10:00AM Eight defensive growth stocks to own right now

Jul 24, 2024 08:08AM Catalyst Pharmaceuticals (CPRX) Enters Exclusive License, Supply and Commercialization Agreement with Kye Pharmaceuticals for AGAMREE in Canada

Apr 2, 2024 10:00AM Here are Oppenheimer’s best Smidcap ideas